Santen is the leading pharmaceutical company in the Japanese prescription ophthalmic pharmaceutical market, having a domestic share of nearly 40 percent and an annual turnover of about 900 Million Euros. Santen specializes in the research, development, manufacturing and marketing of ophthalmic pharmaceuticals with more than 120 years history. Santen is among the few international companies with a focus on eye care. Moreover, Santen has the long-term strategic vision to become one of the top three pharmaceutical companies in the global prescription ophthalmic pharmaceutical market.
Together with the development of internal pipeline and competencies, Santen Europe is also considering external innovative ophthalmic programs. Indeed, the sound financial status of the group gives Santen Europe the opportunity to undertake the investments needed to achieve its ambitious long-term strategic vision.
Start the partnership process. Santen would be delighted to discuss a potential partnership with you. Tell us about your company, product, or opportunity, and a Santen representative will contact you.
Learn more about potential partnerships with our company from www.santen.eu